Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

"Most recently, I had gone up to three different medications to control my hypertension and increasing dosage." The Fairfax Station father says each medication brought different side effects ...

High blood pressure, or hypertension, is a common condition that affects millions of people globally. It significantly ...

Researchers have discovered that a drug commonly used to treat hypertension can extend lifespan and slow down aging. The ...

Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill ...

High blood pressure, or hypertension, affects over 1.5 billion people worldwide and is a leading cause of heart disease and ...

A new study has found that a revolutionary new treatment that combines three existing hypertension medications into one could ...

An upcoming clinical trial will test whether empagliflozin might be able to improve heart health in pulmonary arterial ...

Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension. Read why I ...

Several medications are available to treat high blood pressure, but more than 10 million Americans do not respond to the treatments, according to the American Heart Association.

Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride ...